upgrad equal weight
real inflect point stock past year share
trade previou high august
stock tri break level octob juli septemb
seven month ago decemb stock trade friday follow
releas result stock final broke close all-tim high
evid progress visibl lower appar risk
surround quality/suppli issu believ stock like establish new
higher trade rang believ signific upsid potenti still limit
compani demonstr return market growth market
growth oper leverag thu upgrad stock equal weight
hanson make progress lot work remain sinc appoint ceo
month ago bryan hanson chang senior leadership team put place
measur address challeng manufactur qualiti moral posit
compani return market growth believ progress made though
road ahead still like long one zb end market grow
sustain grow like requir invest may limit abil
significantli expand oper margin also still believ portfolio manag
need make attract stori
valuat sinc share trade ntm ep
averag discount believ discount
med-tech group warrant given prospect slower growth appli zbh
histor averag rel pe would equat ep deriv
price target prior valuat methodolog ep
quarterli annual ep usd
consensu number refinitiv receiv gmt
barclay capit inc and/or one affili seek busi
compani cover research report result investor awar
firm may conflict interest could affect object report investor
consid report singl factor make invest decis
underweight
rais usd
return equiti ttm
link barclay live interact chart
margin return data
balanc sheet cash flow mn
equival
short long-term debt
chang work capit
flow oper
valuat leverag metric
equal weight view appoint
bryan hanson ceo posit catalyst chang
believ orchestr turnaround
howev believ transform need
like take multipl year see prospect
signific sale margin expans
limit near-term
upsid case could driven improv
market trend orthoped greater success
improv price trend strateg
downsid case could driven inabl
receiv and/or execut new product approv
deterior price addit fda regulatori
exchang stronger us dollar dilut
past five year
share
 healthcar
equip suppli
upgrad equal weight
past year share trade previou high
august stock tri break level octob
juli septemb seven month ago decemb stock trade
follow releas result friday stock final broke
close all-tim high close
great quarter view great also wasnt bad
rel histori constant currenc sale growth slightli better expect
still modest ytd advers impact number
bill day even adjust sale growth like less ep came bit better
consensu versu
perhap importantli seem forward estim may final bottom
consist revis lower number year street ep estim
dramat reduc past two half year juli result
consensu estim bottom prior quarter releas
current refinitiv consensu estim dont forese
ep reaching/surpass level
manag narrow rais low end underli sale adjust ep
forecast manag expect constant currenc sale growth acceler see
growth line weight averag market growth rate wamgr
margin expect lower end previou rang
manag commit oper margin expans next year although think
minim howev improv sale forecast lower tax rate gave
manag confid rais low end ep forecast view
favour compani histori concern market regard
cfo transit announc share cfo transit concern
evid progress visibl lower appar risk surround
quality/suppli issu believ stock like establish new higher trade
rang said believ signific upsid potenti still limit compani
demonstr return market growth market growth oper
leverag thu upgrad stock equal weight underweight
revis ep forecast reflect perform
expect ahead ep higher ep
higher slightli ahead consensu
slightli consensu believ manag
look grow ep larg reinvest upsid back busi
move overweight
view prior ceo hanson take compani decemb
zimmer/zimm biomet mismanag strateg financi oper
perspect decad thu believ simpli take time unwind impact
past see follow on-going challeng
zimmer biomet sale mix
significantli weight toward matur major joint replac market
knee sale hip repres largest busi sport
trauma extrem busi account offer zb greater
opportun growth remain sale mix includ dental spine
zb manag estim weight averag market growth rate
wamgr agre zb grow market past five
year eas suppli constraint improv organiz
effect coupl new product introduct believ zb underli
sale growth rate move closer overal market perhap bit
beyond see opportun sustain mid-singl digit top-lin growth
unlik given current sale mix
price headwind like continu pressur margin zb continu face
on-going price pressur orthoped market year-to-d basi zb price
headwind past five year price headwind translat
gross margin pressur per annum cumul basi
longer term manag could look way reduc unit cost still see
price headwind offset much potenti gain also believ
manag look reinvest futur financi leverag back busi
support acceler top line like result limit oper
margin expans particularli near-to-medium term
flow balanc sheet dynam zb earn qualiti gener low
evidenc signific gap adjust ep well free
cash flow perform estim combin zimmer biomet free cash
flow roughli billion organ free cash flow
billion leverag ratio abil transact signific like
limit near term
pleas refer barclay live recent model
-- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- price eros gm per unit cost depuy chang ex-fx barclay zimmer biomet hold inc
zimmer biomet zb sale ep came better street/w
expect counter concern around cfo transit sale
constant currenc basi driven best knee perform year manag
narrow rais low end sale adjust ep guidanc
expect grow line weight averag market growth rate wamgr
begin think manag made progress believ
equal weight rate appropri
addit detail quarter
million except per share data chang sale constant currenc organ basi unless otherwis note
knee sale ahead street expect manag
highlight sale result best growth year
still limit launch rosa knee posit growth close gap without
capit result posit impact knee franchis confid system
grow play materi role
set solid quarter sale ahead street expect
manag expect continu growth enhanc sale special
manag narrow rais low end sale adj ep guidanc
rang re-affirmed intent drive op margin expans
constant currenc sale growth bit better expect still
modest zb continu grow market
gross margin improv reflect benefit fx hedg gain expect
continu balanc along med-tech tax refund help
howev manag note gross margin like declin given
absenc gain continu price environ
spine cmf sale declin
period manag expect
improv spine cmf ahead given distribut channel chang
eas compani anniversari bone cement distribut contract end
set sport extrem trauma
sale constant currenc basi strong growth asia
pacif off-set modest growth emea flattish
sale america
gross margin y/i benefit hedg gain
sg margin y/i compani invest sale market
 margin sale y/i reflect invest spend
oper margin y/i
adjust tax rate y/i
adjust ep street estim shi
estim
zb manag expect grow in-lin wamgr approxim one sell day offset bill day
differ aid growth comparison zb expect gross margin help fx hedg gain refund
constant currenc sale manag expect grow in-lin wamgr
fx expect headwind result flat sale report basi prior
guidanc flat /- oper margin expect rang prior adjust tax rate
expect rang prior narrow ep rang
kristen stewart cfa herebi certifi view express research report accur reflect person view
subject secur issuer refer research report part compens directli indirectli
relat specif recommend view express research report
